Glutathione Injectable Compounded Drug Recalled Due to Sterility Assurance Issues
Tailor Made Compounding recalls Glutathione 200mg/mL injectable vials due to lack of sterility assurance. The FDA Class II recall affects 40 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable product with sterility assurance issues, presenting a risk of infection. No illnesses or injuries have been reported in the source text, so the score is 3 per the rubric criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Tailor Made Compounding (TMC Acquisition LLC) is recalling Glutathione 200mg/mL Preservative Free Injectable, 30mL vials due to lack of assurance of sterility. The recall affects 40 vials distributed nationwide in the USA and Puerto Rico.
The FDA classified this as a Class II recall. The affected batches are: Batch #12062113A2 (expiration date 3/6/2022), Batch #01052209B (expiration date 4/5/2022), and Batch #01312223A1 (expiration date 5/1/2022).
The recalled product
- Product
- Glutathione 200mg/mL Preservative Free, Injectable, 30mL-vial, Refrigerate, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Compounded Injectable
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Batch #: 12062113A2
- Exp 3/6/2022
- 01052209B
- Exp 4/5/2022
- 01312223A1
- Exp 5/1/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01